2018 Volume 42 Issue 2 Pages 147-156
Because of accumulation of information on hyperuricemia and gout since 2010, the 3rd edition of the guideline for the management of hyperuricemia and gout is now going to be processed. After setting the important clinical issues on hyperuricemia and gout, seven clinical questions accompanied by several advantage and disadvantage outcomes have been selected. Using the systematic reviews on reports related to outcome of each clinical question, bias risk of each evidence has been estimated. Taken together with the estimation of body of evidence, the recommendation for the each clinical question will be determined. In addition to clinical questions, review paper regarding the clinical issues of hyperuricemia and gout will be prepared. Thus, this guideline is expected to cover the decision making regarding the important clinical issues on hyperuricemia and gout.
